Select Medical
SEM was delisted on the 30th of June, 2026.
249 hedge funds and large institutions have $2.34B invested in Select Medical in 2023 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 90 increasing their positions, 89 reducing their positions, and 25 closing their positions.
16% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 25
2.06% more ownership
Funds ownership: 141.94% → 144% (+2.1%)
1% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 89
0% more funds holding
Funds holding: 248 → 249 (+1)
5% less capital invested
Capital invested by funds: $2.46B → $2.34B (-$119M)
65% less call options, than puts
Call options by funds: $126K | Put options by funds: $357K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$40.6M |
| 2 |
BlackRock
New York
|
+$17.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.02M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$6.57M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$6.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$40.4M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$11.8M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
-$9.39M |
| 4 |
Goldman Sachs
New York
|
-$8.56M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.91M |
SEM Hedge Fund Activity: Q4 2023 in Review
249 of the 6,865 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q4 2023, worth a combined $2.34B — down 4.8% from $2.46B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new SEM positions and 25 closed out — a net gain of 4 holders — while 90 added to existing stakes and 89 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $40.6M. The largest seller was Hood River Capital Management, cutting an estimated $40.4M.
- 249 institutional investors held Select Medical (SEM) as of Q4 2023, up from 248 in Q3 2023.
- Funds reported $2.34B of Select Medical stock for Q4 2023, down 4.8% quarter-over-quarter.
- 29 funds opened new Select Medical positions in Q4 2023 and 25 closed out, a net change of +4 holders.
- The largest Select Medical buyer in Q4 2023 was Morgan Stanley, an estimated $40.6M added.
- The largest Select Medical seller in Q4 2023 was Hood River Capital Management, an estimated $40.4M sold.
Based on aggregated 13F filings for Q4 2023.